Acadian Asset Management’s Larimar Therapeutics LRMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-53,239
| Closed | -$113K | – | 1763 |
|
|
2025
Q1 | $113K | Buy |
+53,239
| New | +$113K | ﹤0.01% | 1337 |
|
|
2024
Q1 | – | Sell |
-22,692
| Closed | -$103K | – | 1694 |
|
|
2023
Q4 | $103K | Sell |
22,692
-13,255
| -37% | -$60.2K | ﹤0.01% | 1351 |
|
|
2023
Q3 | $141K | Sell |
35,947
-91,280
| -72% | -$358K | ﹤0.01% | 1252 |
|
|
2023
Q2 | $397K | Buy |
127,227
+53,804
| +73% | +$168K | ﹤0.01% | 1109 |
|
|
2023
Q1 | $331K | Buy |
+73,423
| New | +$331K | ﹤0.01% | 1145 |
|
|
2021
Q3 | – | Sell |
-457
| Closed | -$4K | – | 1884 |
|
|
2021
Q2 | $4K | Buy |
+457
| New | +$4K | ﹤0.01% | 1968 |
|
|
2020
Q3 | – | Sell |
-20,106
| Closed | -$259K | – | 2280 |
|
|
2020
Q2 | $259K | Buy |
+20,106
| New | +$259K | ﹤0.01% | 1408 |
|
|
2019
Q4 | – | Sell |
-177,957
| Closed | -$131K | – | 1996 |
|
|
2019
Q3 | $131K | Buy |
+177,957
| New | +$131K | ﹤0.01% | 1420 |
|
|
2019
Q2 | – | Sell |
-141,674
| Closed | -$389K | – | 1948 |
|
|
2019
Q1 | $389K | Buy |
+141,674
| New | +$389K | ﹤0.01% | 1175 |
|
|
2018
Q4 | – | Sell |
-7,880
| Closed | -$92K | – | 1778 |
|
|
2018
Q3 | $92K | Sell |
7,880
-41,256
| -84% | -$482K | ﹤0.01% | 1221 |
|
|
2018
Q2 | $502K | Sell |
49,136
-22,577
| -31% | -$231K | ﹤0.01% | 893 |
|
|
2018
Q1 | $534K | Sell |
71,713
-32,301
| -31% | -$241K | ﹤0.01% | 842 |
|
|
2017
Q4 | $481K | Buy |
104,014
+16,072
| +18% | +$74.3K | ﹤0.01% | 808 |
|
|
2017
Q3 | $310K | Buy |
87,942
+1,338
| +2% | +$4.72K | ﹤0.01% | 850 |
|
|
2017
Q2 | $304K | Buy |
+86,604
| New | +$304K | ﹤0.01% | 900 |
|